Metabolic brain disease

Keyphrases

Publications

volume 39, number 5, 2024

Kuo Chen, Zhengming Huang, Changsheng Liu, Qian Ouyang, Qing Yan, Wei Zheng, Yongkai Huang
Hsa_circ_0004872 mitigates proliferation, metastasis and immune escape of meningioma cells by suppressing PD-L1. Metabolic brain disease 39 (5) (2024)
Zongchi Liu, Zhaohui Chai, Fan Wu, Luyuan Zhang, Yuxiang Weng, Zihan Xu, Yuxiang Weng, Jiangbiao Gong, Jian Shen, Ren-Ya Zhan, Yu Zhu
Transcriptomics and metabolomics reveal hypothalamic metabolic characteristics and key genes after subarachnoid hemorrhage in rats. Metabolic brain disease 39 (5) (2024)
Mahdi Sepidarkish, Narges Kalantari, Tahmineh Gorgani-Firouzjaee, Sahar Rostami-Mansoor, Hoda Shirafkan
Association between insulin resistance and multiple sclerosis: a systematic review and meta-analysis. Metabolic brain disease 39 (5) (2024)
Walaa G Abdelhamid, Noha A Mowaad, Gihan F Asaad, Asmaa F Galal, Sarah S Mohammed, Olfat E Mostafa, Doaa R Sadek, Lobna A Elkhateb
The potential protective effect of Camellia Sinensis in mitigating monosodium glutamate-induced neurotoxicity: biochemical and histological study in male albino rats. Metabolic brain disease 39 (5) (2024)

volume 39, number 6, 2024

Santosh Kumar Prajapati, Arjit Pathak, Puneet K Samaiya
Alzheimer's disease: from early pathogenesis to novel therapeutic approaches. Metabolic brain disease 39 (6) (2024)
Richa Sawant, Angel Godad
An update on novel and emerging therapeutic targets in Parkinson's disease. Metabolic brain disease 39 (6) (2024)
Huma Ikram, Rumaisa Zakir, Darakhshan Jabeen Haleem
Memory enhancing and neuroprotective effects of apomorphine in a rat model of dementia. Metabolic brain disease 39 (6) (2024)
Jie Shen, Qiao Ye, Fang Luo, Tianhang Yu, Jinli Miao, Wenmin Wang, Hui Yuan
Causal relationship between multiple sclerosis and primary Sjögren's syndrome: a two-sample mendelian randomization study. Metabolic brain disease 39 (6) (2024)
Smita Jain, Ankita Murmu, Saraswati Patel
Elucidating the therapeutic mechanism of betanin in Alzheimer's Disease treatment through network pharmacology and bioinformatics analysis. Metabolic brain disease 39 (6) (2024)
Chengcheng Hui, Jinghui Jin, Mengshan Ji, Haibo Wang, Xiaowei Wang, Jianping Ma, Ya Wang, Yanpo Si, Suiqing Chen, Tao Guo
Neuroprotective properties of the Lilium brownii extracts in the experimental model of Parkinson's disease. Metabolic brain disease 39 (6) (2024)
Smita Jain, Ankita Murmu, Saraswati Patel
Elucidating the therapeutic mechanism of betanin in Alzheimer's Disease treatment through network pharmacology and bioinformatics analysis. Metabolic brain disease 39 (6) (2024)
Zhuoying Yu, Jing Yang, Ye Jiang, Min Wei, Yanhan Lyu, Dongsheng Yang, Shixiong Shen, Yongzheng Han, Min Li
Metabolomic and lipidomic profiling of the spinal cord in type 2 diabetes mellitus rats with painful neuropathy. Metabolic brain disease 39 (6) (2024)
Jie Shen, Qiao Ye, Fang Luo, Tianhang Yu, Jinli Miao, Wenmin Wang, Hui Yuan
Causal relationship between multiple sclerosis and primary Sjögren's syndrome: a two-sample mendelian randomization study. Metabolic brain disease 39 (6) (2024)
Michael Sørensen, Mette Munk Enok Lauridsen, Sara Montagnese
The social and psychological impact of hepatic encephalopathy. Metabolic brain disease 39 (6) (2024)
Zhuoying Yu, Jing Yang, Ye Jiang, Min Wei, Yanhan Lyu, Dongsheng Yang, Shixiong Shen, Yongzheng Han, Min Li
Metabolomic and lipidomic profiling of the spinal cord in type 2 diabetes mellitus rats with painful neuropathy. Metabolic brain disease 39 (6) (2024)
Yue Qi, Qilun Zhou, Yongping Zhang, Jinlan Deng, Ruonan Li, Xiaofeng Zhang
Exploring the active components and potential mechanisms of Alpiniae oxyphyllae Fructus in treating diabetes mellitus with depression by UPLC-Q-Exactive Orbitrap/MS, network pharmacology and molecular docking. Metabolic brain disease 39 (6) (2024)
Mette Munk Enok Lauridsen, Lea Ladegaard Grønkjær, Jeppe Holm Atkins, Stine Ulrik Mikkelsen, Tintin Svensson, Nina Kimer, Hartmut Hecker, Gabriele B Beckhoff, Karin Weißenborn, Hendrik Vilstrup
Portosystemic Hepatic Encephalopathy Scores (PHES) differ between Danish and German healthy populations despite their geographical and cultural similarities. Metabolic brain disease 39 (6) (2024)
Richa Sawant, Angel Godad
An update on novel and emerging therapeutic targets in Parkinson's disease. Metabolic brain disease 39 (6) (2024)
Michael Sørensen, Mette Munk Enok Lauridsen, Sara Montagnese
The social and psychological impact of hepatic encephalopathy. Metabolic brain disease 39 (6) (2024)
Michael Sørensen, Mette Munk Enok Lauridsen, Sara Montagnese
The social and psychological impact of hepatic encephalopathy. Metabolic brain disease 39 (6) (2024)
Benxing Yao, Di Xu, Qing Wang, Lin Liu, Ziyun Hu, Wenya Liu, Qi Zheng, Huihui Meng, Ran Xiao, Qian Xu, Yudie Hu, Junsong Wang
Neuroprotective and vasoprotective effects of herb pair of Zhiqiao-Danggui in ischemic stroke uncovered by LC-MS/MS-based metabolomics approach. Metabolic brain disease 39 (6) (2024)
Ramin Mahdipour, Vahid Ebrahimi, Mahmoud Hosseini, Mohammad Soukhtanloo, Seyed HamidReza Rastegar-Moghaddam, Amir Mohammad Malvandi, Abbas Mohammadipour
Grape seed extract protects rat offspring hippocampus from the silicon dioxide nanoparticles' neurotoxicity. Metabolic brain disease 39 (6) (2024)
Cheng-Fu Li, Qiu-Ping Zhang, Jie Cheng, Guang-Hui Xu, Ji-Xiao Zhu, Li-Tao Yi
Role of ginsenoside Rb1 in attenuating depression-like symptoms through astrocytic and microglial complement C3 pathway. Metabolic brain disease 39 (6) (2024)
Ali Niapour, Maryam Abdollahzadeh, Safa Ghaheri Fard, Hakimeh Saadati
The therapeutic potential of 1, 25-dihydroxy vitamin D3 on cisplatin-affected neurological functions is associated with the regulation of oxidative stress and inflammatory markers as well as levels of MMP2/9. Metabolic brain disease 39 (6) (2024)
Santosh Kumar Prajapati, Arjit Pathak, Puneet K Samaiya
Alzheimer's disease: from early pathogenesis to novel therapeutic approaches. Metabolic brain disease 39 (6) (2024)
Benxing Yao, Di Xu, Qing Wang, Lin Liu, Ziyun Hu, Wenya Liu, Qi Zheng, Huihui Meng, Ran Xiao, Qian Xu, Yudie Hu, Junsong Wang
Neuroprotective and vasoprotective effects of herb pair of Zhiqiao-Danggui in ischemic stroke uncovered by LC-MS/MS-based metabolomics approach. Metabolic brain disease 39 (6) (2024)
Jing Wang, Xinmin Li, Junzi Long, Qian Gao, Mengyang Pan, Fangjie Yang, Yasu Zhang
Exploring the therapeutic efficacy and pharmacological mechanism of Guizhi Fuling Pill on ischemic stroke: a meta-analysis and network pharmacology analysis. Metabolic brain disease 39 (6) (2024)
Ya-Zhi Bai, Yongming Zhang, Shuang-Qing Zhang
New horizons for the role of selenium on cognitive function: advances and challenges. Metabolic brain disease 39 (6) (2024)
Zhuoying Yu, Jing Yang, Ye Jiang, Min Wei, Yanhan Lyu, Dongsheng Yang, Shixiong Shen, Yongzheng Han, Min Li
Metabolomic and lipidomic profiling of the spinal cord in type 2 diabetes mellitus rats with painful neuropathy. Metabolic brain disease 39 (6) (2024)
Michael Sørensen, Mette Munk Enok Lauridsen, Sara Montagnese
The social and psychological impact of hepatic encephalopathy. Metabolic brain disease 39 (6) (2024)
Huma Ikram, Rumaisa Zakir, Darakhshan Jabeen Haleem
Memory enhancing and neuroprotective effects of apomorphine in a rat model of dementia. Metabolic brain disease 39 (6) (2024)
Jie Shen, Qiao Ye, Fang Luo, Tianhang Yu, Jinli Miao, Wenmin Wang, Hui Yuan
Causal relationship between multiple sclerosis and primary Sjögren's syndrome: a two-sample mendelian randomization study. Metabolic brain disease 39 (6) (2024)
Ali Niapour, Maryam Abdollahzadeh, Safa Ghaheri Fard, Hakimeh Saadati
The therapeutic potential of 1, 25-dihydroxy vitamin D3 on cisplatin-affected neurological functions is associated with the regulation of oxidative stress and inflammatory markers as well as levels of MMP2/9. Metabolic brain disease 39 (6) (2024)
Mette Munk Enok Lauridsen, Lea Ladegaard Grønkjær, Jeppe Holm Atkins, Stine Ulrik Mikkelsen, Tintin Svensson, Nina Kimer, Hartmut Hecker, Gabriele B Beckhoff, Karin Weißenborn, Hendrik Vilstrup
Portosystemic Hepatic Encephalopathy Scores (PHES) differ between Danish and German healthy populations despite their geographical and cultural similarities. Metabolic brain disease 39 (6) (2024)
Zhuoying Yu, Jing Yang, Ye Jiang, Min Wei, Yanhan Lyu, Dongsheng Yang, Shixiong Shen, Yongzheng Han, Min Li
Metabolomic and lipidomic profiling of the spinal cord in type 2 diabetes mellitus rats with painful neuropathy. Metabolic brain disease 39 (6) (2024)
Yan Wang, Yu-Feng Xue, Yi-Fan Xu, Ming-Wei Wang, Jing Guan, Xi Chen
Elevated serum neurofilament light chain levels are associated with hepatic encephalopathy in patients with cirrhosis. Metabolic brain disease 39 (6) (2024)
Jing Wang, Xinmin Li, Junzi Long, Qian Gao, Mengyang Pan, Fangjie Yang, Yasu Zhang
Exploring the therapeutic efficacy and pharmacological mechanism of Guizhi Fuling Pill on ischemic stroke: a meta-analysis and network pharmacology analysis. Metabolic brain disease 39 (6) (2024)
Cheng-Fu Li, Qiu-Ping Zhang, Jie Cheng, Guang-Hui Xu, Ji-Xiao Zhu, Li-Tao Yi
Role of ginsenoside Rb1 in attenuating depression-like symptoms through astrocytic and microglial complement C3 pathway. Metabolic brain disease 39 (6) (2024)
Mette Munk Enok Lauridsen, Lea Ladegaard Grønkjær, Jeppe Holm Atkins, Stine Ulrik Mikkelsen, Tintin Svensson, Nina Kimer, Hartmut Hecker, Gabriele B Beckhoff, Karin Weißenborn, Hendrik Vilstrup
Portosystemic Hepatic Encephalopathy Scores (PHES) differ between Danish and German healthy populations despite their geographical and cultural similarities. Metabolic brain disease 39 (6) (2024)
Ali Niapour, Maryam Abdollahzadeh, Safa Ghaheri Fard, Hakimeh Saadati
The therapeutic potential of 1, 25-dihydroxy vitamin D3 on cisplatin-affected neurological functions is associated with the regulation of oxidative stress and inflammatory markers as well as levels of MMP2/9. Metabolic brain disease 39 (6) (2024)
Yan Wang, Yu-Feng Xue, Yi-Fan Xu, Ming-Wei Wang, Jing Guan, Xi Chen
Elevated serum neurofilament light chain levels are associated with hepatic encephalopathy in patients with cirrhosis. Metabolic brain disease 39 (6) (2024)
Jie Shen, Qiao Ye, Fang Luo, Tianhang Yu, Jinli Miao, Wenmin Wang, Hui Yuan
Causal relationship between multiple sclerosis and primary Sjögren's syndrome: a two-sample mendelian randomization study. Metabolic brain disease 39 (6) (2024)
Yue Qi, Qilun Zhou, Yongping Zhang, Jinlan Deng, Ruonan Li, Xiaofeng Zhang
Exploring the active components and potential mechanisms of Alpiniae oxyphyllae Fructus in treating diabetes mellitus with depression by UPLC-Q-Exactive Orbitrap/MS, network pharmacology and molecular docking. Metabolic brain disease 39 (6) (2024)
Ya-Zhi Bai, Yongming Zhang, Shuang-Qing Zhang
New horizons for the role of selenium on cognitive function: advances and challenges. Metabolic brain disease 39 (6) (2024)
Farnoosh Usefi, Auob Rustamzadeh, Zahra Ghobadi, Nader Sadigh, Nafiseh Mohebi, Armin Ariaei, Fatemeh Moradi
Rosuvastatin attenuates total-tau serum levels and increases expression of miR-124-3p in dyslipidemic Alzheimer's patients: a historic cohort study. Metabolic brain disease 39 (6) (2024)
Mette Munk Enok Lauridsen, Lea Ladegaard Grønkjær, Jeppe Holm Atkins, Stine Ulrik Mikkelsen, Tintin Svensson, Nina Kimer, Hartmut Hecker, Gabriele B Beckhoff, Karin Weißenborn, Hendrik Vilstrup
Portosystemic Hepatic Encephalopathy Scores (PHES) differ between Danish and German healthy populations despite their geographical and cultural similarities. Metabolic brain disease 39 (6) (2024)
Chengcheng Hui, Jinghui Jin, Mengshan Ji, Haibo Wang, Xiaowei Wang, Jianping Ma, Ya Wang, Yanpo Si, Suiqing Chen, Tao Guo
Neuroprotective properties of the Lilium brownii extracts in the experimental model of Parkinson's disease. Metabolic brain disease 39 (6) (2024)
Yan Wang, Yu-Feng Xue, Yi-Fan Xu, Ming-Wei Wang, Jing Guan, Xi Chen
Elevated serum neurofilament light chain levels are associated with hepatic encephalopathy in patients with cirrhosis. Metabolic brain disease 39 (6) (2024)
Ramin Mahdipour, Vahid Ebrahimi, Mahmoud Hosseini, Mohammad Soukhtanloo, Seyed HamidReza Rastegar-Moghaddam, Amir Mohammad Malvandi, Abbas Mohammadipour
Grape seed extract protects rat offspring hippocampus from the silicon dioxide nanoparticles' neurotoxicity. Metabolic brain disease 39 (6) (2024)
Farnoosh Usefi, Auob Rustamzadeh, Zahra Ghobadi, Nader Sadigh, Nafiseh Mohebi, Armin Ariaei, Fatemeh Moradi
Rosuvastatin attenuates total-tau serum levels and increases expression of miR-124-3p in dyslipidemic Alzheimer's patients: a historic cohort study. Metabolic brain disease 39 (6) (2024)